A preoperative MRI-based radiomics-clinicopathological classifier to predict the recurrence of pituitary macroadenoma within 5 years
Y Zhang, Y Luo, X Kong, T Wan, Y Long, J Ma - Frontiers in neurology, 2022 - frontiersin.org
Objective: To investigate the ability of a MRI-based radiomics-clinicopathological model to
predict pituitary macroadenoma (PMA) recurrence within 5 years. Materials and Methods …
predict pituitary macroadenoma (PMA) recurrence within 5 years. Materials and Methods …
Clinical profiles of silent corticotroph adenomas compared with silent gonadotroph adenomas after adopting the 2017 WHO pituitary classification system
S Jiang, J Zhu, M Feng, Y Yao, K Deng, B Xing, W Lian… - Pituitary, 2021 - Springer
Abstract Purpose Silent corticotroph adenomas (SCAs) can be redefined according to the
2017 World Health Organization pituitary classification system with the introduction of T‑PIT …
2017 World Health Organization pituitary classification system with the introduction of T‑PIT …
Prevalence and clinical characteristics of Crooke's cell adenomas in 101 patients with T-PIT-positive pituitary adenomas: Case series and literature review
D Zhu, Z Wang, T Tian, X Wu, D He, Y Zhu… - Frontiers in …, 2022 - frontiersin.org
Purpose We aimed to perform a retrospective analysis of a rare subtype of corticotroph
adenoma, Crooke's cell adenoma, to better understand its clinical features. Methods We …
adenoma, Crooke's cell adenoma, to better understand its clinical features. Methods We …
Emerging roles of miRNA, lncRNA, circRNA, and their cross-talk in pituitary adenoma
W Wu, L Cao, Y Jia, Y Xiao, X Zhang, S Gui - Cells, 2022 - mdpi.com
Pituitary adenoma (PA) is a common intracranial tumor without specific biomarkers for
diagnosis and treatment. Non-coding RNAs (ncRNAs), including microRNAs (miRNA), long …
diagnosis and treatment. Non-coding RNAs (ncRNAs), including microRNAs (miRNA), long …
Genomics in Cushing's disease: the dawn of a new era
M Reincke, M Theodoropoulou - The Journal of Clinical …, 2021 - academic.oup.com
Symptomatic pituitary tumors represent 5% to 10% of all brain tumors and are mostly benign.
Up to 30% of macroadenomas grow invasively (mostly defined clinically by imaging), 15 …
Up to 30% of macroadenomas grow invasively (mostly defined clinically by imaging), 15 …
Outcome of giant pituitary tumors requiring surgery
S Gaillard, S Adeniran, C Villa, A Jouinot… - Frontiers in …, 2022 - frontiersin.org
Objective The management of giant pituitary tumors is complex, with few publications and
recommendations. Consequently, patient's care mainly relies on clinical experience. We …
recommendations. Consequently, patient's care mainly relies on clinical experience. We …
Clinical, biological, radiological pathological and immediate post-operative remission of sparsely and densely granulated corticotroph pituitary tumors: A retrospective …
B Rak, M Maksymowicz, M Pękul… - Frontiers in …, 2021 - frontiersin.org
Purpose Cushing's disease is the most common cause of endogenous hypercortisolemia
due to a corticotroph pituitary tumor. Up-to-date there is no reliable biomarker of …
due to a corticotroph pituitary tumor. Up-to-date there is no reliable biomarker of …
Trouillas's Grading and Post-Surgical Tumor Residue Assessment in Pituitary Adenomas: The Importance of the Multidisciplinary Approach
R Calandrelli, PP Mattogno, S Chiloiro, M Gessi… - Diagnostics, 2024 - mdpi.com
Background: We aim to assess the role of a multidisciplinary approach in pituitary adenomas
(PitNETs) classification, evaluate criteria concordance, and compare intraoperative …
(PitNETs) classification, evaluate criteria concordance, and compare intraoperative …
Impact of histopathological classification of non-functioning adenomas on long term outcomes: comparison of the 2004 and 2017 WHO classifications
A Chatrath, J Kosyakovsky, P Patel, J Ahn, M Elsarrag… - Pituitary, 2022 - Springer
Purpose Outcomes of patients with non-functioning pituitary adenomas categorized using
the 2004 and 2017 WHO classification systems are understudied. We report outcomes from …
the 2004 and 2017 WHO classification systems are understudied. We report outcomes from …
Differences in invasiveness and recurrence rate among nonfunctioning pituitary neuroendocrine tumors depending on tumor subtype
Purpose To clarify the invasiveness to surrounding structures and recurrence rate of each
subtype of nonfunctioning pituitary neuroendocrine tumor (Pit-NETs) according to the WHO …
subtype of nonfunctioning pituitary neuroendocrine tumor (Pit-NETs) according to the WHO …